Skip to main content
Top
Published in: Medicine, Health Care and Philosophy 3/2020

01-09-2020 | Scientific Contribution

Can reproductive genetic manipulation save lives?

Author: G. Owen Schaefer

Published in: Medicine, Health Care and Philosophy | Issue 3/2020

Login to get access

Abstract

It has recently been argued that reproductive genetic manipulation technologies like mitochondrial replacement and germline CRISPR modifications cannot be said to save anyone’s life because, counterfactually, no one would suffer more or die sooner absent the intervention. The present article argues that, on the contrary, reproductive genetic manipulations may be life-saving (and, from this, have therapeutic value) under an appropriate population health perspective. As such, popular reports of reproductive genetic manipulations potentially saving lives or preventing disease are not necessarily mistaken, though such terminology still requires further empirical validation.
Footnotes
1
While this article will focus on the terminology of ‘saving lives’, the arguments are meant to apply mutatis mutandis to most benefit language pertaining to children born via rGMTs.
 
2
This would comport with focusing on rGMTs’ purported positive impact on societal welfare and overall morbidity/mortality rates. For an application of this more societal-level approach to benefit to MRT, see Wrigley et al. (2015).
 
3
This argument could also be run to show that preimplantation genetic screening, i.e., selecting only embryos for implantation that are free of significant genetic disorders, may be a life-saving intervention. But rGMTs are the focus of this paper because of the life-saving claims surrounding it that have been made; while this language is not used as much for genetic screening, by this argument it might be acceptable to use such language in that context as well.
 
Literature
go back to reference Craven, Lyndsey, Helen A. Tuppen, Gareth D. Greggains, Stephen J. Harbottle, Julie L. Murphy, Lynsey M. Cree, Alison P. Murdoch, et al. 2010. Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature 465: 82–85. https://doi.org/10.1038/nature08958.CrossRef Craven, Lyndsey, Helen A. Tuppen, Gareth D. Greggains, Stephen J. Harbottle, Julie L. Murphy, Lynsey M. Cree, Alison P. Murdoch, et al. 2010. Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature 465: 82–85. https://​doi.​org/​10.​1038/​nature08958.CrossRef
go back to reference Elliot, Robert. 1993. Identity and the ethics of gene therapy. Bioethics 7: 27–40.CrossRef Elliot, Robert. 1993. Identity and the ethics of gene therapy. Bioethics 7: 27–40.CrossRef
go back to reference Engelstad, Kristin, Miriam Sklerov, Joshua Kriger, Alexandra Sanford, Johnston Grier, Daniel Ash, Dieter Egli, et al. 2016. Attitudes toward prevention of mtDNA-related diseases through oocyte mitochondrial replacement therapy. Human Reproduction 31: 1058–1065. https://doi.org/10.1093/humrep/dew033.CrossRef Engelstad, Kristin, Miriam Sklerov, Joshua Kriger, Alexandra Sanford, Johnston Grier, Daniel Ash, Dieter Egli, et al. 2016. Attitudes toward prevention of mtDNA-related diseases through oocyte mitochondrial replacement therapy. Human Reproduction 31: 1058–1065. https://​doi.​org/​10.​1093/​humrep/​dew033.CrossRef
go back to reference HFEA. 2014. Third scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception: 2014 update. HFEA. 2014. Third scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception: 2014 update.
go back to reference Joseph, Rebecca. 2016. 3-parent babies: who’s eligible and what’s ethical? Global News, September 28. Joseph, Rebecca. 2016. 3-parent babies: who’s eligible and what’s ethical? Global News, September 28.
go back to reference Nolte, Ellen, Martin McKee, David Evans, and Marina Karanikolos. 2012. Saving lives? The contribution of health care to population health. In Health systems, health, wealth and societal well-being: assessing the case for investing in health systems, ed. Josep Figueras and Martin McKee, 101–124. Berkshire and New York: Open University Press. Nolte, Ellen, Martin McKee, David Evans, and Marina Karanikolos. 2012. Saving lives? The contribution of health care to population health. In Health systems, health, wealth and societal well-being: assessing the case for investing in health systems, ed. Josep Figueras and Martin McKee, 101–124. Berkshire and New York: Open University Press.
Metadata
Title
Can reproductive genetic manipulation save lives?
Author
G. Owen Schaefer
Publication date
01-09-2020
Publisher
Springer Netherlands
Published in
Medicine, Health Care and Philosophy / Issue 3/2020
Print ISSN: 1386-7423
Electronic ISSN: 1572-8633
DOI
https://doi.org/10.1007/s11019-020-09947-2

Other articles of this Issue 3/2020

Medicine, Health Care and Philosophy 3/2020 Go to the issue

Letter to editor

Letter to Editor